The leading Pharmaceutical and other consumer items manufacturer Johnson & Johnson has applied to the Central Government for permission to administer its recent ‘only 1-dose’ corona vaccine as an emergency trial.
Presently, only 2 vaccines for corona are being administered in India - Covishield and covaxin. The central government also permitted the Russian manufactured Sputnik-V as well.
Subsequently, various other companies manufacturing the corona vaccine have applied to the central government for usage.
One of the leading international pharmaceutical concerns, Johnson & Johnson, have manufactured a corona vaccine that needs to be administered ONLY ONCE.
In the recent trials conducted in several countries with the1-dose Johnson & Johnson vaccine, it has been established that this vaccine has 85% capacity for the prevention of coronavirus.
Further, analysts have also confirmed this vaccine has no side effects.
Subsequently, Johnson & Johnson has applied to the central government for permission to administer this new 1-dose vaccine for the citizens.